Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-29 Sale |
2021-12-30 9:00 pm |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director |
40,400 | $20.3 | $820,120 | 231,098 (Indirect) |
View |
| 2021-12-29 Sale |
2021-12-30 8:55 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
40,400 | $20.3 | $820,120 | 231,098 (Indirect) |
View |
| 2021-12-21 Sale |
2021-12-23 4:13 pm |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director |
119,400 | $19 | $2,268,600 | 234,798 (Indirect) |
View |
| 2021-12-21 Sale |
2021-12-23 4:08 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
119,400 | $19 | $2,268,600 | 234,798 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-17 5:16 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-17 5:13 pm |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director |
393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:22 pm |
Janux Therapeutics Inc. | JANX | Bregua Corp 10% Owner |
58,823 | $17 | $999,991 | 3,749,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-14 Option Award |
2023-06-16 5:07 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:06 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:06 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:36 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:35 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:34 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:33 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:32 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Godfrey Wayne Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:30 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
310,000 | $0 | 310,000 (Direct) |
View |
Ownership |
2023-01-05 4:29 pm |
N/A 2031-03-09 |
Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer |
0 | $0 | 217,629 (Direct) |
View |
| 2022-09-21 Option Award |
2022-09-22 6:00 pm |
N/A 2032-09-20 |
Janux Therapeutics Inc. | JANX | Kung Winston Director |
39,375 | $0 | 39,375 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:39 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:37 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:36 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | McNulty Alana B. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:35 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:33 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Heller Stefan Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:32 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:31 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Simson Jake Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 5:06 pm |
N/A 2032-02-29 |
Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer |
230,000 | $0 | 230,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:28 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Salek-Ardakani Shahram Chief Scientific Officer |
114,250 | $0 | 114,250 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:27 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
116,750 | $0 | 116,750 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:26 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
106,750 | $0 | 106,750 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:23 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Godfrey Wayne Chief Medical Officer |
114,250 | $0 | 114,250 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:21 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
354,250 | $0 | 354,250 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-09 5:36 pm |
N/A 2031-09-06 |
Janux Therapeutics Inc. | JANX | McNulty Alana B. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-09 5:34 pm |
N/A 2031-09-06 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-07-20 4:44 pm |
N/A 2031-05-13 |
Janux Therapeutics Inc. | JANX | Salek-Ardakani Shahram Chief Scientific Officer |
0 | $0 | 416,325 (Direct) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:22 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Bregua Corp 10% Owner |
6,571,323 | $0 | 3,749,250 (Direct) |
View |